ResidualPlaybeta

Hitman: Blood Money

Io-Interactive A/S · 2007 · $9.99 · Action · deal grade A

  • Estimated net residual revenue: $6.2k to $9.3k per month
  • Opportunity: $16.2k per month at x2.10 dormancy
  • Estimated lifetime owners: 1.0M
  • 94%% positive across 16028 reviews · 143.7 reviews/month

Why it's flagged

  • Developer silent for 7.8 years
  • Studio active elsewhere (4 titles tracked), so this one may welcome a partner
  • Last build shipped 12.5 years ago
  • Store page localized in only 1 language(s)

Analyst notes (AI-assisted)

Hitman: Blood Money is a 2006 stealth-sandbox assassination game that remains a franchise high point and earns $7.7k/mo despite zero active marketing.

Blood Money generates consistent residual revenue ($7.7k/mo mid, up to $9.3k/mo high) on a $9.99 price point with 94% positive reviews and ~144 reviews/mo. The title sits dormant but profitable, owned outright by Io-Interactive, and commands strong franchise loyalty across both legacy and new-to-series players. For a publisher seeking a no-risk evergreen catalog title or Io-Interactive seeking to optimize legacy IP monetization, this is a clean acquisition or remaster candidate with minimal legal overhead. Most realistic play: acquisition.

  • Risk: Player reports indicate persistent compatibility issues (cursor locking, black-screen save reloads) that deter conversion despite strong concept appeal; mod workarounds exist but fragment user experience.
  • Risk: Zero discounting in >18 months and no developer engagement in >7 months suggest low prioritization; risk that publisher has deprioritized legacy title support.
  • Risk: Franchise trajectory: Absolution (2013) and World of Assassination trilogy (2016-2021) overshadow Blood Money in critical and player mindshare, limiting upsell to modern audience.

This case as Markdown · Estimates carry ±30-50%% error per title.